Recently, DeNardo and coll reported that, in breast cancer, some antitumoral drugs induce the production of both IL-34 and M-CSF by mammary epithelial cells, suggesting that, in some circumstances, therapeutic strategies may favor tumor immune escape [25]. The gene discussed is CSF1; the disease is neoplasm.